Please turn JavaScript on
MPP icon

MPP

Subscribe in seconds and receive MPP's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.

You can select the updates using tags or topics and you can add as many websites to your feed as you like.

And the service is entirely free!

Follow MPP: MPP Home - The Medicines Patent Pool

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.38 / day

Message History

originally posted on LinkedIn.

—

by Amina Larbi,


Read full story

To further strengthen regional supply resilience and diversify manufacturing capacity, MPP has launched a targeted regional Expression of Interest (EOI), open exclusively to eligible manufacturers from the Latin American and Caribbean region, to recruit one additional licensee for baloxavir marboxil, an innovative antiviral treatment for influenza recommended by the World Hea...


Read full story

Carlo Giaquinto, Professor of Paediatrics, President of the Penta Foundation and coordinator of the Penta ID Network

RSV causes severe illness and pneumonia in young children, particularly in low- and middle-income countries. MPP is exploring how voluntary licensing could support earlier, more affordable access to new RSV medi...


Read full story

The Medicines Patent Pool (MPP), Belgian biotechnology company SwiftPharma and South Africa’s Council for Scientific and Industrial Research (CSIR) signed a binding agreement to transfer innovative plant-based ...


Read full story